American International Group’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-16,793
| Closed | -$1.8M | – | 3242 |
|
|
2023
Q1 | $1.8M | Buy |
16,793
+334
| +2% | +$35.8K | 0.01% | 981 |
|
|
2022
Q4 | $1.81M | Buy |
16,459
+1,925
| +13% | +$212K | 0.01% | 976 |
|
|
2022
Q3 | $858K | Buy |
14,534
+836
| +6% | +$49.4K | 0.01% | 1268 |
|
|
2022
Q2 | $387K | Sell |
13,698
-1,182
| -8% | -$33.4K | ﹤0.01% | 1781 |
|
|
2022
Q1 | $562K | Sell |
14,880
-1,048
| -7% | -$39.6K | ﹤0.01% | 1660 |
|
|
2021
Q4 | $630K | Buy |
15,928
+9,742
| +157% | +$385K | ﹤0.01% | 1672 |
|
|
2021
Q3 | $147K | Sell |
6,186
-147
| -2% | -$3.49K | ﹤0.01% | 2609 |
|
|
2021
Q2 | $156 | Buy |
+6,333
| New | +$156 | ﹤0.01% | 2662 |
|